Evidence map›Paper›PMID 37824210›Full record

ArticleChemistryOpen2024

Direct Detection of Viral Infections from Swab Samples by Probe-Gated Silica Nanoparticle-Based Lateral Flow Assay.

Dilara Buse Durdabak, Soner Dogan, Serap Demir Tekol, Caner Celik, Veli Cengiz Ozalp, Bilge Guvenc Tuna

Abstract read
In one paragraph

Article in ChemistryOpen, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dilara Buse DurdabakDepartment of Biophysics Faculty of Medicine, Yeditepe University, Istanbul, 34755, Turkey.
Soner DoganDepartment of Medical Biology Faculty of Medicine, Yeditepe University, Istanbul, 34755, Turkey.
Serap Demir TekolDepartment of Clinical Microbiology, University of Health Sciences Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, 34865, Turkey.
Caner CelikDepartment of Emergency Medical Service, Memorial Sisli Hospital, Istanbul, Turkey.
Veli Cengiz OzalpDepartment of Medical Biology Faculty of Medicine, Atilim University, Ankara, 06830, Turkey.
Bilge Guvenc TunaDepartment of Biophysics Faculty of Medicine, Yeditepe University, Istanbul, 34755, Turkey.ORCID 0000-0003-1348-1336

Funding

GEBIP grantTurkish Academy of Sciences
6 · The paper itself

Abstract

Point-of-care diagnosis is crucial to control the spreading of viral infections. Here, universal-modifiable probe-gated silica nanoparticles (SNPs) based lateral flow assay (LFA) is developed in the interest of the rapid and early detection of viral infections. The most superior advantage of the rapid assay is its utility in detecting various sides of the virus directly from the human swab samples and its adaptability to detect various types of viruses. For this purpose, a high concentration of fluorescein and rhodamine B as a reporting material was loaded into SNPs with excellent loading capacity and measured using standard curve, 4.19 μmol ⋅ g

Indexed as

COVID-19NanoparticlesCOVID-19 TestingHumansPoint-of-Care SystemsSARS-CoV-2detection of viral infectionfluorescence-based LFAgated-SNPslateral flow assaysilica nanoparticles

Identifiers

PMID37824210
PMCPMC10853071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.